Sun.May 15, 2022

Striking new snake species discovered in Paraguay

Scienmag

A beautiful non-venomous snake, previously unknown to science, was discovered in Paraguay and described by researchers of the Paraguayan NGO Para La Tierra with the collaboration of Guyra Paraguay and the Instituto de Investigación Biológica del Paraguay.

Axion BioSystems Welcomes Biotech Industry Leader Kevin Gould as New CEO

BioTech 365

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Weights can be weapons in battle against obesity

Scienmag

People battling with their weight who are unable to do aerobic exercise can hit the gym instead and still see positive results. Credit: N/A People battling with their weight who are unable to do aerobic exercise can hit the gym instead and still see positive results.

83

Element Nutritional Sciences to Report Record Revenue in Q1 2022

BioTech 365

Element Nutritional Sciences to Report Record Revenue in Q1 2022 Element Nutritional Sciences to Report Record Revenue in Q1 2022 Element expected to report revenue between $2.0 million and $2.3 million, with a gross margin between 35% and 40%, or … Continue reading → Business Wire

52

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Many Black men with “normal” lung function may actually have emphysema

Scienmag

Session: A14, Investigating COPD Health Inequities Date and Time: 9:40 a.m. PT, Sunday, May 15, 2022 Location: Room 201-202 (South Building, Level 2), Moscone Center Credit: ATS Session: A14, Investigating COPD Health Inequities Date and Time: 9:40 a.m.

Atamyo Therapeutics Announces Significant Milestones for ATA-100 and ATA-200, its Gene Therapy Programs to Treat Limb-Girdle Muscular Dystrophy 2I/R9 and 2C/R5

BioTech 365

More Trending

ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in Three Posters at the ATS 2022 International Conference

BioTech 365

ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in Three Posters at the ATS 2022 International Conference ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in … Continue reading → Business Wire

52

Lights, catalyst, reaction! Converting CO2 to formic acid using an alumina-supported, iron-based compound

Scienmag

Photoreduction of CO2 into transportable fuel like formic acid (HCOOH) is a great way of dealing with CO2’s rising levels in the atmosphere.

Urovant Sciences® Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting

BioTech 365

Urovant Sciences® Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at the 2022 American Urological Association Meeting Urovant Sciences® Presents New Data from EMPOWUR Study, Advancing Knowledge of the Treatment of Overactive Bladder at … Continue reading → Business Wire

52

Potentially dangerous synthetic cooling agents are used at high levels in E-cigarettes and refillable vaping liquids

Scienmag

Session: A25, Tobacco and THC Health Science Date and Time: 9:30 – 11:00 a.m. PST, Sunday, May 15, 2022 Location: Room 303-304 (South Building, Level 3), Moscone Center Credit: ATS Session: A25, Tobacco and THC Health Science Date and Time: 9:30 – 11:00 a.m.

82

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

BioTech 365

Extraterrestrial stone brings first supernova clues to Earth

Scienmag

New chemistry ‘forensics’ indicate that the stone named Hypatia from the Egyptian desert could be the first tangible evidence found on Earth of a supernova type Ia explosion. These rare supernovas are some of the most energetic events in the universe.

82

PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma

BioTech 365

PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma PT027, a Novel Fixed-Dose Combination of Albuterol and … Continue reading → Business Wire

Robotic surgery is safer and improves patient recovery time

Scienmag

Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly (20 per cent) less time in hospital, concludes a first-of-its kind clinical trial led by scientists at UCL and the University of Sheffield. The study, published in JAMA and funded by The Urology Foundation with […]. Latest News improves patient recovery robotic Safer Surgery time

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Which pharmaceutical companies have the most drug patents in Portugal?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Portugal?

Drugs 52

Robotic surgery improves patient recovery time

Scienmag

A new study, published in JAMA, has found that robotic surgery reduces the chance of readmission by half (52 per cent), and revealed a “striking” four-fold (77 per cent) reduction in prevalence of blood clots (deep vein thrombus and pulmonary emboli) – a significant cause of health decline and morbidity – when compared to patients […]. Latest News improves patient recovery robotic Surgery time

63

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

BioTech 365

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease WALTHAM, Mass. and SHANGHAI, … Continue reading → GlobeNewswire

Drugs 40

How common is readmission after hospitalization for COVID-19?

Scienmag

For patients discharged after hospitalization for COVID-19, death or readmission was common, with about 11% being readmitted or dying within 30 days, according to new research published in CMAJ (Canadian Medical Association Journal) [link] Hospital readmissions are known to be common and costly. Knowing the readmission rate after COVID-19 hospitalization and understanding the related resource […]. Latest News common COVID19 hospitalization readmission

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline

BioTech 365

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline Arimoclomol is an NDA-stage, revenue-generating investigational drug candidate being developed for the … Continue reading → GlobeNewswire

Drugs 40

Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine, national study finds

Scienmag

The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics. It is estimated that in 2021 the vaccine, the most widely used against COVID-19 in the US, prevented 8.7 million […]. Latest News COVID19 deaths finds hospitalizations National PfizerBioNTech prevented study vaccine

Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis

BioTech 365

Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis — The FDA has accepted an IND application supporting clinical development of ANG-3070 in … Continue reading → GlobeNewswire

Benefits of PSA prostate cancer screening found to be more favorable than previous estimates, especially for blacks

Scienmag

New research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve University found that prostate cancer screening with the prostate specific antigen (PSA) blood test has remarkably favorable tradeoffs. This is particularly true for Black men, the investigators found, who disproportionately bear the burden of prostate […]. Latest News benefits Blacks cancer estimates favorable previous prostate PSA screenin

Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

BioTech 365

Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine Saint Herblain (France), May 16, 2022 – Valneva SE (Nasdaq: … Continue reading → GlobeNewswire

Study shows children’s physical activity levels fell below national guidelines in wake of pandemic

Scienmag

New research has revealed children’s physical activity levels in the UK were significantly lower by the time the COVID-19 pandemic public lockdown restrictions were lifted. The study, led by the University of Bristol, found that by the end of 2021 little more than a third (36%) were meeting the national recommended physical activity guidelines. While […]. Latest News activity childrens fell guidelines levels National pandemic Physical shows study wake

ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

BioTech 365

ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing … Continue reading → GlobeNewswire

AAAS announces addition of Ecosystem Health and Sustainability to Science Partner Journal program

Scienmag

The American Association for the Advancement of Science (AAAS) is pleased to announce its partnership with the Ecological Society of China (ESC) to publish Ecosystem Health and Sustainability as a Science Partner Journal. Ecosystem Health and Sustainability (EHS), launched in 2015, publishes high-quality research on advances in sustainability ecology and how global environmental change affects […].

Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project

BioTech 365

Xlife Sciences AG / Key word(s): Miscellaneous Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project 16.05.2022 / 07:05 Xsight Optics, based in Jena (Germany), a project company of Xlife Sciences AG (SIX: … Continue reading → EQS Newsfeed

40

¿Hasta dónde llegarías cuando un ser querido tiene una enfermedad terminal?

NY Times

Tener acceso a un medicamento experimental suele implicar procesos poco claros y decisiones éticas difíciles. Drugs (Pharmaceuticals) Clinical Trials Death and Dying

QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels

BioTech 365

QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels QIAstat-Dx Rise, which can process up to 56 tests in … Continue reading → Business Wire

40

Images of Illness—Sharing Patient Photographs in a Pandemic

JAMA Internal Medicine

This essay discusses the sharing of patient photographs by clinicians on social media during the COVID-19 pandemic

Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.

BioTech 365

Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc. Orphazyme A/S in restructuringCompany announcementNo. 24/2022Inside … Continue reading → GlobeNewswire

40

Morning After Pill: Pills To Prevent Pregnancy

Druggist

The ‘Morning after Pill’ is frequently referred to as emergency contraception (EC). It is used to prevent pregnancy after unprotected sex. This pill prevents pregnancy by delaying the ovulation cycle and does not induce abortion.

Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

BioTech 365

Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving … Continue reading → GlobeNewswire

40